These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9380818)

  • 1. Survival chance in papillary thyroid cancer in Hungary: individual survival probability estimation using the Markov method.
    Esik O; Tusnády G; Daubner K; Németh G; Füzy M; Szentirmay Z
    Radiother Oncol; 1997 Sep; 44(3):203-12. PubMed ID: 9380818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival potentials of patients with papillary carcinoma of the thyroid gland in Hungary].
    Esik O; Tusnády G; Daubner K; Németh G; Füzy M; Szentirmay Z
    Orv Hetil; 1996 May; 137(20):1067-78. PubMed ID: 8657418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markov model-based estimation of individual survival probability for medullary thyroid cancer patients.
    Esik O; Tusnády G; Trón L; Boér A; Szentirmay Z; Szabolcs I; Rácz K; Lengyel E; Székely J; Kásler M
    Pathol Oncol Res; 2002; 8(2):93-104. PubMed ID: 12172572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PATHYPRE: Pascal program for the estimation of the individual course of patients with papillary thyroid cancer].
    Esik O; Rejtó L; Tusnády G
    Orv Hetil; 1997 Apr; 138(15):939-42. PubMed ID: 9173384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival.
    Akslen LA; Varhaug JE
    Cancer; 1995 Nov; 76(9):1643-54. PubMed ID: 8635070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.
    Chowdhury S; Veyhl J; Jessa F; Polyakova O; Alenzi A; MacMillan C; Ralhan R; Walfish PG
    Oncotarget; 2016 May; 7(22):32318-28. PubMed ID: 27086918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece.
    Tzavara I; Vlassopoulou B; Alevizaki C; Koukoulis G; Tzanela M; Koumoussi P; Sotsiou F; Thalassinos N
    Clin Endocrinol (Oxf); 1999 May; 50(5):643-54. PubMed ID: 10468931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Tumor Size on Risk of Metastatic Disease and Survival for Thyroid Cancer: Implications for Biopsy Guidelines.
    Nguyen XV; Roy Choudhury K; Tessler FN; Hoang JK
    Thyroid; 2018 Mar; 28(3):295-300. PubMed ID: 29373949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of papillary thyroid carcinoma: uni- and multivariate analysis of prognostic factors (TNM staging system included).
    Pelizzo MR; Toniato A; Grigoletto R
    J Exp Clin Cancer Res; 1997 Sep; 16(3):261-5. PubMed ID: 9387899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
    Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
    J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of invasive extranodal extension on the prognosis of patients with papillary thyroid carcinoma.
    Moritani S
    Thyroid; 2014 Dec; 24(12):1779-83. PubMed ID: 25157399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
    Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
    Ebina A; Sugitani I; Fujimoto Y; Yamada K
    Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer.
    Wang LY; Palmer FL; Nixon IJ; Thomas D; Patel SG; Shaha AR; Shah JP; Tuttle RM; Ganly I
    Thyroid; 2014 Nov; 24(11):1594-9. PubMed ID: 25162180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.